Neurontin and its new, more powerful version, Lyrica, an analgesic for the treatment of fibromyalgia pain, are widely used for the treatment of untagged indications that pose a clear public hazard. The use of these blockbuster drugs was approved even though the FDA had no idea what it was actually doing in the brain. New shocking study shows they block the formation of new brain synapses, dramatically reducing the potential for regeneration of brain plasticity – which means that these drugs will cause a decline in the brain faster than any substance known to mankind .
The problem of these drugs is compounded by their blatant illegal commercialization. Neurontin was approved by the FDA in 1994 for the treatment of epilepsy. The pain medication for fibromyalgia was the subject of a massive illegal off-label promotion that cost Warner-Lambert $ 430 million (the first-ever fine for off-label promotion). The pain medication for fibromyalgia now belongs to Pfizer. Pfizer also owns Lyrica, an extremely powerful version of Neurontin. It has been approved by the FDA for various types of pain and fibromyalgia.
Lyrica for the relief of fibromyalgia is one of four drugs illegally marketed by a Pfizer subsidiary, which resulted in a $ 2.3 billion settlement against Pfizer. Although the marketing of these drugs has been heavily sanctioned, they continue to generate billions of dollars in sales from non-compliant uses. Doctors use them for all sorts of nervous problems because they are effective in suppressing symptoms. However, such uses can no longer be justified because the actual mechanism of drugs is finally understood and they result in a significant reduction in nerve health in the long run.The researchers in the study above are trying to minimize the severity of the drugs by saying that “adult neurons do not form many new synapses”. It’s just not true.
The new science shows that brain health during aging is based on the formation of new synapses. Even these researchers have been able to question the common use of these drugs in pregnant women. How is a fetus supposed to make new nerve cells when the mother takes a blocking medicine? These are the kinds of situations that the FDA should be everywhere. As usual, the FDA is considering a suicide warning for Lyrica, a pain reliever for the treatment of fibromyalgia, while its non-labeled uses include bipolar disorder and migraine headaches. The FDA is likely to turn the thumbs for the next decade on the problem of brain damage. Attention consumer.